Deconstructed cover image

Medicare Drug Pricing Negotiations Advance

Deconstructed

CHAPTER

Medicare Drug Pricing Negotiations and the Impact on Insulin

This chapter explores how Medicare drug pricing negotiations can benefit both Medicare beneficiaries and the general public, with a specific focus on the impact on insulin prices. It discusses the current out-of-pocket cap on insulin for Medicare beneficiaries, the need to negotiate lower prices, and the potential implications for pharmaceutical corporations.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner